Arm lymphedema after vascularized lymph node harvest following Covid-19 vaccination

References

• Swissmedic. Reports of suspected adverse reactions to COVID-19 vaccines in Switzerland – update 29. 2023.
   Google Scholar
• Pratibha A, Stahel Vincent P. The safety of Covid-19 mRNA vaccines: a review. Patient Safety Surg. 2021;15:1–5.
   PubMed Web of Science ®Google Scholar
• Masayuki M. The lymphatic system and COVID-19 vaccines. Front Immunol. 2022;13:1041025.
   PubMed Web of Science ®Google Scholar
• Schaverien Mark V, Ido B, Patel Ketan M, et al. Vascularized lymph node transfer for lymphedema. Semin Plast Surg. 2018;32(01):028–035. doi:10.1055/s-0038-1632401.
   PubMedGoogle Scholar
• Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann NY Acad Sci. 2008;1131(1):147–154. doi:10.1196/annals.1413.014.
   PubMedGoogle Scholar
• Smeltzer David M, Stickler Gunnar B, Alexander S. Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics. 1985;76:206–218.
   PubMed Web of Science ®Google Scholar
• Grada AA, Phillips TJ. Lymphedema: pathophysiology and clinical manifestations. J Am Acad Dermatol. 2017;77(6):1009–1020. doi:10.1016/j.jaad.2017.03.022.
   PubMed Web of Science ®Google Scholar
• Chung J-H, Hwang Y-J, Park S-H, et al. Preliminary outcomes of combined surgical approach for lower extremity lymphedema: supraclavicular lymph node transfer and lymphaticovenular anastomosis. J Plast Surg Hand Surg. 2022;56(5):261–269. doi:10.1080/2000656X.2021.1964980.
   PubMed Web of Science ®Google Scholar
• Ciudad P, Agko M, Perez Coca JJ, et al. Comparison of long-term clinical outcomes among different vascularized lymph node transfers: 6-year experience of a single center’s approach to the treatment of lymphedema. J Surg Oncol. 2017;116(6):671–682. doi:10.1002/jso.24730.
   PubMed Web of Science ®Google Scholar
• Cohen D, Krauthammer SH, Wolf I, et al. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18 F] FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging. 2021;48(6):1854–1863. doi:10.1007/s00259-021-05314-2.
   PubMed Web of Science ®Google Scholar
• Ha SM, Chu AJ, Lee J, et al. US evaluation of axillary lymphadenopathy following COVID-19 vaccination: a prospective longitudinal study. Radiology. 2022;305(1):46–53. doi:10.1148/radiol.220543.
   PubMed Web of Science ®Google Scholar
• Okazaki T, Matashiro M, Kodama G, et al. Frequent onsets of cellulitis in lower limbs with lymphedema following COVID-19 mRNA vaccination. Vaccines. 2022;10(4):517. doi:10.3390/vaccines10040517.
   Web of Science ®Google Scholar
• Chung J-H, Sohn S-M, Yoo H-J, et al. Transient lower extremity lymphedema following COVID-19 vaccination: a case report. Medicine. 2021;100(48):e28092. doi:10.1097/MD.0000000000028092.
   PubMed Web of Science ®Google Scholar
• Hosseinzadeh A, Ebrahimi K, Shahriarirad R, et al. Lower limb lymphedema and cellulitis as a complication of COVID-19 vaccine: a case report. Clin Case Rep. 2022;10(12):e6317. doi:10.1002/ccr3.6317.
   PubMed Web of Science ®Google Scholar
• A, Cristina M, E, Biancamaria C, Alberto, et al. Lymphedema of the arm after COVID-19 vaccination in a patient with hidden breast cancer and paraneoplastic dermatomyositis. Vaccines. 2022;10:1219.
   Web of Science ®Google Scholar
• Gratzon A, Schultz J, Secrest K, et al. Clinical and psychosocial outcomes of vascularized lymph node transfer for the treatment of upper extremity lymphedema after breast cancer therapy. Ann Surg Oncol. 2017;24(6):1475–1481. doi:10.1245/s10434-016-5614-4.
   PubMed Web of Science ®Google Scholar
• Dionyssiou D, Demiri E, Tsimponis A, et al. A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer. Breast Cancer Res Treat. 2016;156(1):73–79. doi:10.1007/s10549-016-3716-0.
   PubMed Web of Science ®Google Scholar
• Brown S, Mehrara BJ, Coriddi M, et al. A prospective study on the safety and efficacy of vascularized lymph node transplant. Ann Surg. 2022;276(4):635–653. doi:10.1097/SLA.0000000000005591.
   PubMed Web of Science ®Google Scholar
• Viitanen TP, Mäki MT, Seppänen MP, et al. Donor-site lymphatic function after microvascular lymph node transfer. Plast Reconstr Surg. 2012;130(6):1246–1253. doi:10.1097/PRS.0b013e31826d1682.
   PubMed Web of Science ®Google Scholar